Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Pharmacogenomics Informed Medications Management Service

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

This public procurement record has 2 releases in its history.

Award

03 Sep 2024 at 09:54

Award Notice
Tender

29 Nov 2021 at 10:24

Tender Notice
Summary of the contracting process

The Common Services Agency, more commonly known as NHS National Services Scotland (NSS), had initiated a procurement process titled "Pharmacogenomics Informed Medications Management Service" under the CPV classification for pharmacy services. The procurement, conducted within the "services" category, aimed to secure an Innovation Partner to develop an integrated Pharmacogenomics and Pharmaceutical Clinical Decision Support Service for NHS Scotland. The project, slated for two phases, includes a patient trial in Greater Glasgow and Clyde and potentially a wider rollout across NHS Scotland if the initial phase proves viable. The procurement commenced with a selective method, initially taken at the tender stage in November 2021 with submissions closing in January 2022. Despite these efforts, the contract status is currently marked as cancelled, and the procurement was lastly updated on 3rd September 2024.

This procurement offered significant potential for business growth, particularly for companies specialising in pharmacogenomics, pharmaceutical clinical decision support systems, and integration of medical technology into electronic health records. It was particularly suited for firms capable of meeting rigorous regulatory requirements, managing innovative projects, and providing educational programmes to enhance clinician and public understanding of pharmacogenomics. The project’s focus on patient safety and tailored medication regimes underscored its importance. The estimated contract value was £66 million with robust criteria favouring quality and performance, making it an attractive opportunity for highly qualified and innovative businesses in the pharmaceutical and healthcare technology sectors.

How relevant is this notice?

Notice Information

Notice Title

Pharmacogenomics Informed Medications Management Service

Notice Description

This requirement is to identify an Innovation Partner who will develop an integrated Pharmacogenomics and Pharmaceutical Clinical Decision Support Service for NHS Scotland which will safely identify patients at greatest risk of harm from multiple medication and produce an efficient, safe and effective medication regime that is tailored to meet their changing needs.

Lot Information

Lot 1

The Authority is procuring the provision of an integrated pharmacogenomics and pharmaceutical clinical decision support service which will safely identify patients at greatest risk of harm from multiple medication and produce an efficient, safe and effective medication regime that is tailored to meet the patient's changing needs. The developed solution will need to comply with any and all regulatory requirements. The solution to be developed by the tenderers should aim to provide enabling tools to implement pharmacogenetic testing and integration into electronic health records and clinical decision support systems, comprising, but not limited to: - Pharmacogenetic panel - Clinical decision support system that is approved and regulated in line with the medical device regulations and any subsequent requirements that may be produced for operating within the United Kingdom. Tenderers will be responsible for registering and managing the developed software as a medical device (SAMD) for the duration of the awarded framework agreement and for elements of Phase 2c of the Procurement (please see the Invitation to Tender - Introductory Information document for details of the Procurement phases) as required and deemed by the Authority (if available). - Technology to integrate into primary and secondary care electronic health record systems, and the resource to support the integration into each of the Authority and Participating Authorities systems as outlined in the ITT and Associated Documentation. - An education programme for the purpose of improving clinicians and pharmacists' confidence and familiarity with pharmacogenomics and also to support public understanding and acceptance. The Project will consist of 2 phases. Phase 1 will consist of an appropriately powered patient trial (circa 10,000 to 20,000 patients) at Greater Glasgow and Clyde which must be delivered within 30 months or less from the award date of the contract. Phase 1 will determine the clinical and economic viability of the project. Following completion of Phase 1 the Authority will either: terminate the agreement; extend into Phase 2 with no change to the agreement; Re-negotiate a number of points with the Innovation Partner and enter into Phase 2. Any renegotiation of the Framework Agreement following phase 1 will be in line with Regulation 72 of The Public Contracts (Scotland) Regulations 2015. Phase 2 is the potential widespread adoption of the service across NHS Scotland. The Authority intends to award a framework agreement to one (1) supplier (being the successful tenderer who will become the "Contractor"), however the Authority reserves the right to award a place on the above noted framework agreement to more than one supplier. Full details of the Service can be found within the PIMM documentation which is included in the PQQ/ITT. Additional information: this is an Innovation Partnership Procurement

Renewal: This framework includes the option to extend for up to a total period of thirty (30) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02fad8
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/028052-2024
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Services
Procurement Method
Selective
Procurement Method Details
Innovation partnership
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services

CPV Codes

85149000 - Pharmacy services

Notice Value(s)

Tender Value
£66,000,000 £10M-£100M
Lots Value
£66,000,000 £10M-£100M
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
3 Sep 20241 years ago
Submission Deadline
5 Jan 2022Expired
Future Notice Date
Not specified
Award Date
3 Sep 20241 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Cancelled
Lots Status
Cancelled
Awards Status
Unsuccessful
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland
Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...